References
1. Martinez-Garcia MA, Garcia-Ortega A., Oscullo G. Practical tips for bronchiectasis for primary care. NPJ Prim Care Respir Med. 8 Sept. 2022;32(1):33. Doi: 10.1038/s41533-022-00297-5.
2. Magge A., Ashraf S., Quittner AL, Metersky ML Quality of life in patients with bronchiectasis: a 2-year longitudinal study. Untransmed. 2019 Jul;7(14):334. Doi: 10.21037/atm.2019.06.62
3. Martínez-García MA, Olveira C., Máiz L. et al. Bronchiectasis: A complex and heterogeneous disease. Arch Bronconeumol (Engl Ed). 2019 Aug;55(8):427-433. Doi: 10.1016/j.arbres.2019.02.024.
4. Sly PD, Gangell CL, Chen L. et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med. 23 May 2013;368(21):1963-70. Doi: 10.1056/NEJMoa1301725
5. José RJ, Brown JS Bronchiectasis. Br J Hosp Med (Rondo). 2014 Oct;75 Suppl 10:C146-51. Doi: 10.12968/hmed.2014.75.Sup10.C146
6. McShane PJ, Naureckas ET, Tino G., Strek ME Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013 Sep 15;188(6):647-56. Doi: 10.1164/rccm.201303-0411CI
7. King PT Pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2009;4:411-9. Doi: 10.2147/copd.s6133
8. Zhang AB, Bilton D. Exacerbation of cystic fibrosis: 4–non-cystic fibrosis bronchiectasis. rib cage. 2008 Mar;63(3):269-76. Doi: 10.1136/thx.2006.060913
9. Goeminne PC, Hernandez F., Diel R. et al. Economic Burden of Bronchiectasis – Known and Unknown: A Systematic Review. BMC Palm Med. 2019-02-28;19(1):54. Doi: 10.1186/s12890-019-0818-6
10. Vidaillac C., Chotirmall SH, Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and treatment. Expert Rev Respir Med. 2021 May;15(5):649-662. Doi: 10.1080/17476348.2021.1906225
11. Hilliam Y., Moore MP, Lamont IL et al. Adaptation and diversification of Pseudomonas aeruginosa in the non-cystic fibrosis bronchiectasis lung. Eur Respir J. 2017 Apr 26;49(4):1602108. Doi: 10.1183/13993003.02108-2016
12. Tabor DE, Oganesyan V., Keller AE et al. Pseudomonas aeruginosa PcrV and Psl, the molecular targets of the bispecific antibody MEDI3902, are conserved among diverse global clinical isolates. J Infect Dis. 2018 Nov 5;218(12):1983-1994. Doi: 10.1093/infdis/jiy438